Products Directorate (TPD) – Timeliness of drug

Products Directorate (TPD) – Timeliness of drug approvals, safety, and pharmaceutical policy Principle: Public Administration Assigned Lobbying Strategy: Student presenters at the Canadian Nurses Association (CNA) annual meeting 1. Define and differentiate the following concepts (Lexchin, 2019) as applied to Zlomislic’s (2013) newspaper article and select another media scan news article on the same topic • Health Canada: Therapeutic Product Directorate (TPD) • Client pluralism • Business transformation strategy/Smart regulation • User fees from pharmaceutical companies 2. Discuss how these concepts influence TPD’s role in facilitating timely drug approvals. 3. Critique the relationship between TPD and pharmaceutical companies to analyze issues related to: • Potential conflicts of interest in the drug approval process (i.e., between pharmaceutical companies and the Health Canada branch of TPD). • Drug safety information that TPD receives from pharmaceutical companies; and • TPD’s ability to release information regarding medications. 4. Examine the degree to which TPD services and information are publicly administrated, nonprofit, and open to public audit.

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."